Bedaquiline
Back to searchMolecule Structure
Scientific Name
Bedaquiline
Description of the Drug
Bedaquiline is a diarylquinoline antimycobacterial used in combination with other antibacterials to treat pulmonary multidrug resistant tuberculosis (MDR-TB).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08903
http://www.drugbank.ca/drugs/DB08903
Brand Name(s)
Sirturo
Company Owner(s)
Janssen Therapeutics Div Janssen Products Lp
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| ATP synthase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364166 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL295482 | ||
| DrugBank | DB08903 | ||
| PubChem: Thomson Pharma | 16896675 | ||
| PubChem | 5388906 | ||
| Nikkaji | J2.291.406E | ||
| PDBe | BQ1 | ||
| BindingDB | 50063995 | ||
| DrugCentral | 4741 | ||
| Brenda | 217360 | ||
| Guide to Pharmacology | 11171 | ||
| rxnorm | SIRTURO | BEDAQUILINE | BEDAQUILINE FUMARATE |
| PubChem: Drugs of the Future | 81044374 | ||
| KEGG Ligand | C14122 | ||
| ChEBI | 72292 | ||
| ZINC | ZINC000004655029 |
